09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

The range of potency values is summarized in Table 2. It is based primarily on the range for Aroclors<br />

1260, 1254, 1242, and 1016 in female Sprague-Dawley rats (Brunner et al., 1996), but considers the<br />

other available studies also.<br />

Table 2. Range of human potency and slope estimates (from US EPA, 1996a)<br />

ED10<br />

(mg/kg-d)<br />

LED10 a<br />

(mg/kg-d)<br />

Central slope b<br />

(mg/kg-d) -1<br />

Upper-bound slope c<br />

(mg/kg-d) -1<br />

Highest observed potency 0.086 0.046 1.2 2.2<br />

Lowest observed potency 2.4 1.4 0.04 0.07<br />

a 95% lower bound on ED10.<br />

b Computed as 0.10/ED10 and rounded to one significant digit.<br />

c Computed as 0.10/LED10 and rounded to one significant digit.<br />

The new upper-bound slopes are lower than the previous estimate of 7.7 per mg/kg-d average lifetime<br />

exposure (U.S. EPA, 1988). The previous estimate was derived from female rats in the Norback and<br />

Weltman (1985) study; the new estimate from the same study is 2.2 per mg/kg-d. This difference is<br />

attributable to three factors, each responsible for reducing the slope by approximately one-third: a rat<br />

liver tumor reevaluation (Moore et al., 1994), use of the new cross-species scaling factor (U.S. EPA,<br />

1996b), and not using a time-weighted average dose. The difference between the highest observed<br />

new upper-bound slope (2.2 per mg/kg-d) and the lowest (0.07 per mg/kg-d) is entirely attributable to<br />

the availability of tests on several commercial mixtures (Brunner et al., 1996). This 30-fold range in<br />

potency reflects differences in commercial mixture composition, as reflected in Table 3.<br />

Table 3.<br />

Typical composition (%) of some commercial Aroclor PCB mixtures<br />

(from US EPA, 1996a)<br />

1016 1242 1248 1254 1260<br />

Mono-CBs 2 1 — — —<br />

Di-CBs 19 13 1 — —<br />

Tri-CBs 57 45 21 1 —<br />

Tetra-CBs 22 31 49 15 —<br />

Penta-CBs — 10 27 53 12<br />

Hexa-CBs — — 2 26 42<br />

Hepta-CBs — — — 4 38<br />

Octa-CBs — — — — 7<br />

Nona-CBs — — — — 1<br />

Deca-CB — — — — —<br />

U.S. EPA (1991) examined the toxic effects, including cancer, of four structural classes: dioxin-like<br />

PCBs, ortho-substituted PCBs, hydroxylated metabolites, and sulfonated metabolites. Different<br />

mechanisms were discussed for dioxin-like and other PCBs. It was concluded that congener toxicity<br />

491

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!